
    
      The duration of the study will include the following periods:

        -  Pretreatment: 28 to 7 days before first infusion

        -  Treatment: Weekly for the first four consecutive weeks during 5-week treatment cycle

        -  Post-treatment: 3 - 4 weeks after last infusion.

      Treatment may be continued until disease progression or unacceptable toxicity or patient
      refusal.
    
  